Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.8600
+0.1795 (26.38%)
At close: Aug 13, 2025, 4:00 PM
0.8140
-0.0460 (-5.35%)
Pre-market: Aug 14, 2025, 9:16 AM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $17.74 million as of August 14, 2025. Its market cap has decreased by -64.40% in one year.
Market Cap
17.74M
Enterprise Value
8.55M
1-Year Change
-64.40%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $17.74M, a decrease of -89.72%. That is a compound annual growth rate of -39.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 17.74M | -30.89% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |